ARDX

ARDX

USD

Ardelyx Inc. Common Stock

$5.695-0.005 (-0.088%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$5.700

High

$5.780

Low

$5.630

Volume

2.70M

Company Fundamentals

Market Cap

1.4B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

3.69M

Exchange

NGM

Currency

USD

52-Week Range

Low $3.21Current $5.695High $6.78

Related News

Analyst Upgrades

Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10

Piper Sandler analyst Christopher Raymond maintains Ardelyx with a Neutral and raises the price target from $9 to $10.

View more
Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10
GlobeNewswire

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet

View more
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
Analyst Upgrades

Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11

Citigroup analyst Yigal Nochomovitz maintains Ardelyx with a Buy and raises the price target from $10 to $11.

View more
Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11
Analyst Upgrades

TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10

TD Cowen analyst Joseph Thome maintains Ardelyx with a Buy and raises the price target from $9 to $10.

View more
TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10